Bank of America’s Intersect ENT, Inc XENT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-572,442
| Closed | -$16M | – | 8794 |
|
|
2022
Q1 | $16M | Buy |
572,442
+56,562
| +11% | +$1.55M | ﹤0.01% | 2375 |
|
|
2021
Q4 | $14.1M | Buy |
515,880
+251,593
| +95% | +$6.82M | ﹤0.01% | 2579 |
|
|
2021
Q3 | $7.19M | Buy |
264,287
+229,239
| +654% | +$5.67M | ﹤0.01% | 3200 |
|
|
2021
Q2 | $599K | Sell |
35,048
-20,104
| -36% | -$376K | ﹤0.01% | 5281 |
|
|
2021
Q1 | $1.15M | Buy |
55,152
+10,394
| +23% | +$240K | ﹤0.01% | 4717 |
|
|
2020
Q4 | $1.02M | Buy |
44,758
+199
| +0.4% | +$3.79K | ﹤0.01% | 4482 |
|
|
2020
Q3 | $727K | Sell |
44,559
-78,563
| -64% | -$1.42M | ﹤0.01% | 4447 |
|
|
2020
Q2 | $1.67M | Buy |
123,122
+4,782
| +4% | +$55.6K | ﹤0.01% | 3758 |
|
|
2020
Q1 | $1.4M | Buy |
118,340
+75,472
| +176% | +$1.67M | ﹤0.01% | 3778 |
|
|
2019
Q4 | $1.07M | Sell |
42,868
-95,016
| -69% | -$1.93M | ﹤0.01% | 4458 |
|
|
2019
Q3 | $2.35M | Sell |
137,884
-21,050
| -13% | -$383K | ﹤0.01% | 3912 |
|
|
2019
Q2 | $3.62M | Buy |
158,934
+4,817
| +3% | +$130K | ﹤0.01% | 3536 |
|
|
2019
Q1 | $4.96M | Buy |
154,117
+8,791
| +6% | +$272K | ﹤0.01% | 3176 |
|
|
2018
Q4 | $4.09M | Sell |
145,326
-51,837
| -26% | -$1.52M | ﹤0.01% | 3204 |
|
|
2018
Q3 | $5.67M | Sell |
197,163
-1,907
| -1% | -$57.3K | ﹤0.01% | 3061 |
|
|
2018
Q2 | $7.46M | Sell |
199,070
-23,064
| -10% | -$905K | ﹤0.01% | 2751 |
|
|
2018
Q1 | $8.73M | Buy |
222,134
+7,703
| +4% | +$281K | ﹤0.01% | 2533 |
|
|
2017
Q4 | $6.95M | Sell |
214,431
-39,562
| -16% | -$1.19M | ﹤0.01% | 2816 |
|
|
2017
Q3 | $7.91M | Buy |
253,993
+121,385
| +92% | +$3.59M | ﹤0.01% | 2738 |
|
|
2017
Q2 | $3.71M | Buy |
132,608
+29,333
| +28% | +$664K | ﹤0.01% | 3313 |
|
|
2017
Q1 | $1.77M | Buy |
103,275
+3,892
| +4% | +$54.5K | ﹤0.01% | 3979 |
|
|
2016
Q4 | $1.2M | Sell |
99,383
-38,415
| -28% | -$497K | ﹤0.01% | 4202 |
|
|
2016
Q3 | $2.18M | Buy |
137,798
+11,421
| +9% | +$172K | ﹤0.01% | 3575 |
|
|
2016
Q2 | $1.63M | Buy |
126,377
+24,012
| +23% | +$376K | ﹤0.01% | 3797 |
|
|
2016
Q1 | $1.95M | Buy |
102,365
+19,627
| +24% | +$356K | ﹤0.01% | 3591 |
|
|
2015
Q4 | $1.86M | Sell |
82,738
-11,649
| -12% | -$230K | ﹤0.01% | 3863 |
|
|
2015
Q3 | $2.21M | Buy |
94,387
+90,883
| +2,594% | +$2.51M | ﹤0.01% | 3670 |
|
|
2015
Q2 | $100K | Buy |
3,504
+2,883
| +464% | +$75.6K | ﹤0.01% | 5586 |
|
|
2015
Q1 | $16K | Buy |
+621
| New | +$14.2K | ﹤0.01% | 6138 |
|
Bank of America's XENT Position: Q2 2022 in Review
Bank of America sold out of Intersect ENT, Inc (XENT) in Q2 2022, closing a stake of 572,442 shares — an estimated $16M sold.
Bank of America first reported a position in XENT in Q1 2015 and held it in 29 quarters. The position peaked at $16M in Q1 2022. 0 funds tracked by Wall St. Rank hold XENT as of Q2 2022.
- Bank of America reported no remaining Intersect ENT, Inc position as of Q2 2022 after selling out during the quarter.
- Bank of America sold 572,442 Intersect ENT, Inc shares in Q2 2022, an estimated $16M.
- Bank of America first reported a position in Intersect ENT, Inc in Q1 2015 and held it in 29 quarters.
- Bank of America's Intersect ENT, Inc position peaked at $16M in Q1 2022.
- 0 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q2 2022.
Based on Bank of America's 13F filing for Q2 2022, filed 12 Aug 2022.